a moderately diabetic control (10 mice per group), two diabetic groups administered IJ orally (1000 mg/kg, 9 mice per group), one diabetic group administered gliclazide (40 mg/kg, 9 mice). Blood samples were collected from the tail vein for the measurement of blood glucose at 7 and 18 d after administration.
In the second test, mice were divided into five groups: normal, diabetic control, diabeticϩIJR (500 mg/kg), diabeticϩ IJP (250 mg/kg) and diabeticϩmetformin (250 mg/kg). The blood glucose levels were measured at 7 and 20 d after administration. There were 10 mice in each group.
Measuring of Water Intake and Food Consumption After the administration of IJ, IJR and IJP, the intake of water of every group was measured every day, and the consumption of food was measured each two days until the test ended.
Measuring Organ Weight (Liver, Spleen and Kidney) After the experiment ended, mice body weights were measured and their eyes were excised to collect blood samples. The mice were dissected, and their livers, kidneys and spleens were extracted to weigh and calculate indexes of organ weight (organ weight/body weight).
Determination of Plasma Cholesterol, Triglyceride, Glycosylated Albumin and Insulin Levels Serum obtained after centrifugation was used for the estimation of total cholesterols (TC), triglyceride (TG), glycosylated albumin (Fruc), HDL-cholesterols (HDL-TC) and insulin levels. These biochemical parameters were determined by an automatic analyzer (7170S, HITACHI) and radio-immuno-analyzer (FT-630, Beijing Nuclear Instrument Factory) using commercial kits.
Oral Glucose Tolerance Test (OGTT) After fasting for 16 h, normal mice were divided into three groups: normal control, normalϩIJ (1000 mg/kg b.w., orally) and normalϩmetformin (175 mg/kg b.w., orally). Untreated diabetic mice were also divided into three groups: diabetic control, diabeticϩIJ (same dose) and diabeticϩmetformin (same dose). There were five mice in every group. After the administration of IJ and metformin for 1.0 h, glucose (2.0 g/kg b.w.) was administrated orally to these mice. Blood glucose levels were measured from the tail vein at 0, 30, 60, 90, 150 and 270 min after the glucose load. Two control groups also received the same glucose load.
Statistical Analysis All results are presented as the meanϮS.D. The data were analyzed for statistical significance by one-way ANOVA test. Results were considered significant at pϽ0.05.
RESULTS

Hypoglycemic Effect of IJ, IJR, and IJP in Diabetic Mice
The effects of IJ on blood glucose levels of severe and moderate alloxan-induced diabetic mice were shown in the first test (Table 1 ). The results showed that IJ significantly lowered blood glucose levels in all diabetic mice, and the hypoglycemic activity was better than with gliclazide.
IJ was divided two fractions (IJR and IJP) by ethanol-precipitation. The effects of IJR and IJP on blood glucose levels in diabetic mice are listed in Table 2 . The results showed that IJR and IJP both significantly reduced blood glucose levels in alloxan-induced diabetic mice. Their hypoglycemic effects were compared with metformin.
Effects of IJ on Organ Weight (Liver, Spleen and Kidney) in Diabetic Mice Table 3 showed the effects of IJ on indexes of three organs (liver, spleen and kidney) after administration for 18 d. The results revealed that kidney in- dexes in severely and moderately untreated-diabetic mice all increased significantly (pϽ0.001, pϽ0.05 respectively), and the index of spleen in severely untreated-diabetic mice decreased compared with normal mice (pϽ0.05), but the index of liver in these diabetic mice did not exhibit more change compared with normal control mice. After treatment with IJ for 18 d, kidney swelling of diabetic mice was ameliorated to near normal value, but spleen atrophy of diabetic mice did not show improvement.
Effect of IJ on Plasma Cholesterol, Triglyceride, Glycosylated Albumin and Insulin Levels in Alloxan-Induced Diabetic Mice Hypercholesterolemia and hyperlipidemia are common complications of diabetes mellitus. Glycosylated albumin is an interim product of AGE (advanced glycated end products). The effects of IJ on these biochemical parameters in alloxan-induced diabetic mice are shown in Table 4 . Compared to levels in normal mice, serum total cholesterol and triglyceride levels tended to increase in untreated-diabetic mice after alloxan was injected for 21 d, and the glycosylated albumin level increased significantly (pϽ0.001). After the treatment of IJ for 18 d, there was a significant decrease (pϽ0.05) in serum triglyceride compared with normal and diabetic control mice (pϽ0.05), but plasma cholesterol and glycosylated albumin levels did not change. Plasma insulin levels in untreated-diabetic mice was reduced markedly compared with normal mice (pϽ0.001), whereas IJ was found to raise serum insulin levels markedly (pϽ0.05).
Effect of IJR and IJP on Plasma Total Cholesterol, Triglyceride and HDL-Cholesterol Levels in Diabetic Mice In the second test, the diabetic mice were given IJR (500 mg/kg) and IJP (250 mg/kg) separately for 20 d. The effects of IJR and IJP on plasma total cholesterol, triglyceride and HDL-cholesterol levels in alloxan-induced diabetic mice are shown in Table 5 . The results indicated IJP was a hypolipidemic active fraction of IJ (pϽ0.05).
Effect of IJ, IJR and IJP on Water Intake and Food Consumption The effect of IJ and its two fractions on the intake of water and food is shown in Figs. 1 and 2 . The data showed that IJ, IJR and IJP significantly reduced the consumption of water and food in diabetic mice compared with the untreated-diabetic control, and that the effect of IJR was better than metformin.
Effect of IJ on Glucose Tolerance in Normal and Diabetic Mice After fasting for 16 h, normal mice and diabetic mice were pretreated separately by the oral administration of IJ (1.0 g/kg) and metformin (175 mg/kg) for 1.0 h. Hyperglycemia was induced by glucose load (2 g/kg, orally). Plasma glucose levels were determined before glucose administration (0 min) and at 30, 60, 90, 150, 270 min later. The results showed that IJ and metformin lowered baseline glucose levels (0 min) in normal mice (pϽ0.05) compared with untreated normal mice. After glucose load, IJ could not effectively inhibit hyperglycemia, whereas metformin significantly exhibited anti-hyperglycemic activity in normal mice at 30-150 min (pϽ0.01). In contrast, blood glucose levels were lowered significantly at 60-150 min (pϽ0.05) in the diabetic mice administered IJ after glucose load. The anti-hyperglycemic effect of IJ was better than metformin (as shown in Table 6 ).
DISCUSSION
The main characteristics of diabetes mellitus are polydipsia, polyuria and polyphagia, weight loss, muscle weakness and hyperglycemia. This work evaluated the effects of aqueous-extracts of I. japonica on biochemical parameters such as: serum triglycerides, cholesterol, HDL-cholesterol, insulin and plasma glucose, water and food intake and glucose tolerance in alloxan-induced diabetic mice. I. japonica, a wellknown traditional Chinese medicinal herb, possesses diverse biological activities and pharmacological function. However, the hypoglycemic and hypolipidemic activities of the herb have not been reported.
The results of this study indicated that an aqueous-extract of I. japonica not only possesses a significant hypoglycemic effect, but also hypolipidemic activity in alloxan-induced diabetic mice. The extract decreased consumption of water and food in diabetic mice, and improved the symptoms of polydipsia, polyuria and polyphagia. From the results of OGTT, IJ did not effectively inhibit hyperglycemia induced by glucose load in normal mice, but it lowered blood glucose levels of diabetic mice significantly at 60-150 min after glucose load. The anti-hyperglycemic effect of the extract was better than metformin. Based on these beneficial effects, I. japonica may be considered a supplementary herbal therapy for diabetic patients to prevent hyperglycemia and hyperlipidemia. The data may be helpful in the treatment of diabetic and/or hyperlipidemia patients in the future. Diabetes is a disorder of carbohydrate, fat and protein metabolism attributed to the diminished production of insulin or mounting resistance to its action. Chronic hyperglycemia leads to secondary complications affecting the eyes, kidneys, nerves and arteries. 10) Besides the use of insulin, oral chemical drugs are widely used for controlling hyperglycemia. Gliclazide is a kind of sulphonylurea. Sulphonylureas act by closing the K ϩ -ATP dependent channel, opening Ca 2ϩ channels, increasing intracellular Ca 2ϩ , and accelerating insulin secretion.
11) Sulphonylureas produce hypoglycemia in nondiabetic animals which have retained some normal pancreatic b-cells, but sulphonylureas do not significantly reduce hyperglycemia in alloxan-induced diabetic mice because their pancreatic b-cells were damaged seriously by alloxan.
12) Metformin is a biguanide drug which inhibits gluconeogenesis in 458 Vol. 29, No. 3 the liver, increases low-affinity and high-affinity receptors of insulin, and improves insulin resistance. 13) Alpha-glucosidase inhibitors delay the absorption of dietary carbohydrates by blocking the digestion of starch in the upper small intestine, and thus reduce postprandial glycemic peaks. 14) Since the aqueous extract of I. japonica (IJ) lowered hyperglycemia in alloxan-diabetic mice, it is possible that its mechanism is different from sulphonylureas. IJ increased plasma insulin levels in alloxan-diabetic mice, which suggests that IJ has an anti-autoimmune inflammatory effect induced by alloxan, partly reverses immune defects of pancreatic islet cells, and helps recover their function of insulin secretion. Kobayashi et al. reported that an aqueous extract from the flowers of I. britannica subsp. I. japonica (IB) reduced the degree of insulitis and destruction of beta-cells induced by streptozotocin, inhibited IFN-g production, and had a preventive effect on autoimmune diabetes by regulating cytokine production. 15) Other probable mechanisms by which IJ lowered blood glucose levels in diabetic mice may be by increasing glycogenesis, inhibiting gluconeogenesis in the liver, or inhibiting the absorption glucose from the intestine. These studies are underway for further elucidation.
Alloxan is a toxic reagent. It causes renal hypertrophy and severe abnormalities in renal transaminase and serum parameters: urea N, creatinine, glutamic-oxalacetic transminase and glutamate-pyruvate transminase activities in diabetic dogs. 16) Following alloxan treatment (1-14 d), the no. of lymphocytes in the thymus and spleen was reduced, which induced spleen atrophy in diabetic animals. 17) In the present study, the results showed that IJ significantly improved renal hypertrophy. This finding may be helpful for the prevention and treatment of diabetic nephropathy. IJ did not counteract the remarkable atrophy of the spleen induced by alloxan in diabetic mice.
In conclusion, these results suggest that an aqueous-extract of I. japonica has potential anti-diabetic and hypolipidemic activities, improves the symptoms of polydipsia, polyuria and polyphagia, and counteracts kidney dysfunction in diabetic mice. Pharmacological, biochemical, histological and chemical studies are needed to further elucidate these findings.
